Brief: Biosergen Q4 Consolidated Net Loss At SEK 15.0 Million
31/03/2022 13:03
March 31 (Reuters) - Biosergen AB BIOSGN.ST :
* BIOSERGEN PUBLISHES INTERIM REPORT FOR FOURTH QUARTER 2021
* Q4 CONSOLIDATED GROUP REVENUE SEK 8.9 MILLION
* Q4 CONSOLIDATED NET LOSS SEK 15.0 MILLION
Source text for Eikon: ID:nWkr7TJ4LX
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million